Charles River Laboratories (CRL)

Exchange
NYSE
Symbol
CRL
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    228.99
  • High
    230.02
  • Low
    208.55
  • Close
    214.20
  • Volume
    2,284,540

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
3.61
Receivables turnover
5.25
Payables turnover
8.12
Working capital turnover
7.40
Days of inventory on hand (DOH)
101.16
Days of sales outstanding (DSO)
69.52
Number of days of payables
44.94
Fixed asset turnover
2.50
Total asset turnover
0.50
 Liquidity ratios
Current ratio
1.52
Quick ratio
1.00
Cash ratio
0.26
Cash conversion cycle
125.74
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
2.28
Interest coverage
5.21
 Profitability ratios
Gross profit margin
66.51%
Operating profit margin
15.07%
Pretax margin
14.05%
Net profit margin
11.58%
Operating return on assets (Operating ROA)
7.53%
Return on assets (ROA)
5.79%
Return on total capital
19.80%
Return on equity (ROE)
13.20%